Production and characterization of monoclonal antibodies specific to lactotriaosylceramide

Glycobiology

Volumn 20, Issue 12, 2010, Pages 1631-1642

  Nozaki, Hirofumi ^a,g   Yanagida, Mayumi ^a   Koide, Ken Ichi ^a   Shiotani, Kazusa ^a   Kinoshita, Mikio ^a   Kobayashi, Yoshiyasu ^a   Watarai, Shinobu ^b   Nakamura, Kazuo ^c   Suzuki, Akemi ^d   Ariga, Toshio ^e   Kushi, Yasunori ^a,f  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b Osaka Prefecture University   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKAI UNIVERSITY   (Japan)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

^f NIHON UNIVERSITY   (Japan)

^g NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

amino CTH; characteristic amino acid sequences; hybridoma cells; IgM subclass; lactotriaosylceramide; monoclonal antibodies; nLc5Cer; transferrin; variable regions

Indexed keywords

CARBOHYDRATE; CERAMIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTOTRIAOSYLCERAMIDE; MONOCLONAL ANTIBODY; TRANSFERRIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CARBOHYDRATE ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FETUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYBRIDOMA CELL CULTURE; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODY SPECIFICITY; FEMALE; HL-60 CELLS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; K562 CELLS; LACTOSYLCERAMIDES; MICE; MICE, INBRED BALB C; U937 CELLS;

MUS;

EID: 78149353706     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwq117     Document Type: Article

References (56)

1. Amersdorfer P, Wong C, Chen S, Smith T, Deshpande S, Sheridan R, Finnern R, Marks JD. 1997. Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries. Infect Immun. 65:3743-3752.
2. Ariga T, Yu RK. 2005. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities. J Neurosci Res. 80:1-17.
3. Boffey J, Okada M, Nicoll D, Wagner ER, Townson K, Bowes T, Conner J, Furukawa K, Willison HJ. 2005. Characterization of immunoglobulins variable region gene usage encoding the murine anti-ganglioside antibody repertoire. J Neuroimmunol. 165:92-103.
4. Chen ZC, Radic MZ, Galili U. 2000. Gene coding evolutionary novel anti-carbohydrate antibodies: studies on anti-Gal production in alpha 1, 3galac-tosyltransferase knock out mice. Mol Immunol. 37:455-466.
5. Cheng X, Zhang Y, Kotani N, Watanabe T, Lee S, Wang X, Kawashima I, Tai T, Taniguchi N, Honke K. 2005. Production of a recombinant single-chain variable-fragment (scFv) antibody against sulfoglycolipid. J Biochem. 137: 415-421.
6. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:156-159.
7. Dasgupta S, Hogan EL, Glushka J, van Halbeek H. 1994. Branched monosialo gangliosides of the lacto-series isolated from bovine erythrocytes: characterization of a novel ganglioside, NeuGc-isooctaosylceramide. Arch Biochem Biophys. 310:373-384.
8. Faguet GB, Agee JF. 1993. A simple technique for the rapid enrichment of class and subclass hybridoma switch variants. A 1000-fold enrichment in half the time, for half the cost. J Immunol Methods. 165:217-224.
9. Fenderson BA, O'Brien DA, Millette CF, Eddy EM. 1984. Stage-specific expression of three cell surface carbohydrate antigens during murine spermatogenesis detected with monoclonal antibodies. Dev Biol. 103:117-128.
10. Fleury D, Barrere R, Bizebard T, Daniels RS, Skehel JJ, Knossow M. 1999. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptors binding site. Nat Struct Biol. 6:530-534.
11. Francois C, Marshall RD, Neuberger A. 1962. Carbohydrates in protein. 4. The determination of mannose in hen's-egg albumin by radioisotope dilution. Biochem J. 83:335-341.
12. Grillo M, Margolis FL. 1990. Use of reverse transcriptase polymerase chain reaction to monitor expression of intronless genes. Biotechniques. 9, 262, 264:266-268.
13. Hakomori S, Kannagi R. 1983. Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst. 71:231-251.
14. Hakomori S. 1984. Tumor-associated carbohydrate antigens. Annu Rev Immunol. 2:103-126.
15. Hakomori S-I. 1994. Glycobiology and the brain. In: Nicolini M and Zetta PF, editors. Oxford, UK: Pergamon Press pp. 86-96.
16. Hakomori SI. 2002. Inaugural article: the glycosynapse. Proc Natl Acad Sci USA. 99:225-232.
17. Henion TR, Zhou D, Wolfer DP, Jungalwala FB, Hennet T. 2001. Cloning of a mouse beta 1, 3 N-acetylglucosaminyltransferase GlcNAc(beta 1, 3)Gal(beta 1, 4) Glc-ceramide synthase gene encoding the key regulator of lacto-series glycolipid biosynthesis. J Biol Chem. 276:30261-30269.
18. Holmes EH, Greene TG. 1991. Isolation and fine-structure characterization of four monoclonal antibodies reactive with glycoconjugates containing terminal GlcNAc residues: application to aspects of lacto-series tumor antigen biosynthesis. Arch Biochem Biophys. 288:87-96.
19. Hu J, Stults CL, Holmes EH, Macher BA. 1994. Structural characterization of intermediates in the biosynthetic pathway of neolacto glycosphingolipids: differential expression in human leukaemia cells. Glycobiology. 4:251-257.
20. Iriko H, Nakamura K, Kojima H, Iida-Tanaka N, Kasama T, Kawakami Y, Ishizuka I, Uchida A, Murata Y, Tamai Y. 2002. Chemical structures and immunolocalization of glycosphingolipids isolated from Diphyllobo-thrium hottai adult worms and plerocercoids. Eur J Biochem. 269: 3549-3559.
21. Ishikawa D, Taki T. 2000. Thin-layer chromatography blotting using polyviny-lidene difluoride membrane (far-eastern blotting) and its applications. Methods Enzymol. 312:145-157.
22. Kannagi R. 2000. Monoclonal anti-glycosphingolipid antibodies. Methods Enzymol. 312:160-179.
23. Kawashima I, Nakamura O, Tai T. 1992. Antibody responses to ganglio-series gangliosides in different strains of inbred mice. Mol Immunol. 29:625-632.
24. Kennett RH. 1979. Cell fusion. Methods Enzymol. 58:345-359.
25. Kushi Y, Tsunoda A, Komatsuzaki A, Watanabe K, Kasama T, Handa S. 1995. Characterization of blood-group-ABO(H)-active glycosphingolipids in type-AB human erythrocytes. Eur J Biochem. 231:862-867.
26. Kushi Y, Shimizu M, Watanabe K, Kasama T, Watarai S, Ariga T, Handa S. 2001. Characterization of blood group ABO(H)-active gangliosides in type AB erythrocytes and structural analysis of type A-active gangliosides variants in type A human erythrocytes. Biochim Biophys Acta. 1525:58-69.
27. Leger OJP, Saldanha JW. 2000. Preparation of recombinant antibodies from immune rodent spleen and the design of the humanization by CDR grafting in monoclonal antibodies. In: Shepherd P and Dean C, editors. Oxford: Oxford University Press pp. 25-65.
28. Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, Ginsburg V. 1982. A monoclonal-antibody defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fuco-pentaose II. J Biol Chem. 257:14365-14369.
29. Magnani JL. 1987. Immunostaining free oligosaccharides directly on thin-layer chromatograms. Methods Enzymol. 138:208-212.
30. Mansson JE, Mo HQ, Egge H, Svennerholm L. 1986. Trisialosyllactosylcera- mide (GT3) is a ganglioside of human lung. FEBS Lett. 196:259-262.
31. Marks C, Marks JD. 1996. Phage libraries\-a new route to clinically useful antibodies. N Engl J Med. 335:730-733.
32. Nohara-Uchida K, Ohashi M. 1987. Isolation and characterization of major gangliosides from frog liver. J Biochem. 102:923-932.
33. O'Keefe TL, Bandyopadhyay S, Datta SK, Imanishi-Kari T. 1990. V region sequences of an idiotypically connected family of pathogenic anti-DNA autoantibodies. J Immunol. 144:4275-4283.
34. Paulson JC. 1989. Glycoproteins: what are the sugar chains for? Trends Biochem Sci. 14:272-276.
35. Reid LC. 1979. Cloning. Methods Enzymol. 58:152-164.
36. Rothman P. 1993. Interleukin 4 targeting of immunoglobulin heavy chain class-switch recombination. Res Immunol. 144:579-583.
37. Sambroo J, Russell DW. 2001. Molecular cloning, a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press pp. 6.1-7.88.
38. Shitara K, Fujiwara K, Igarashi S, Ohta S, Furuya A, Nakamura K, Koike M, Hanai N. 1994. Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG. J Immunol Methods. 169:83-92.
39. Spira G, Bargellesi A, Teillaud JL, Scharff MD. 1984. The identification of monoclonal class switch variants by sib selection and an ELISA assay. J Immunol Methods. 74:307-315.
40. Steplewski Z, Spira G, Blaszczyk M, Lubeck MD, Radbruch A, Illges H, Herlyn D, Rajewsky K, Scharff M. 1985. Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants. Proc Natl Acad Sci USA. 82:8653-8657.
41. Svennerholm L. 1963. Chromatographic separation of human brain ganglio-sides. J Neurochem. 10:613-623.
42. Sweeley CC. 1969. Chromatography on columns of silicic acid. Methods Enzymol. 14:254-267.
43. Symington FW, Fenderson BA, Hakomori S. 1984. Fine specificity of a monoclonal anti-testicular cell antibody for glycolipids with terminal N-acetyl-D-glucosamine structure. Mol Immunol. 21:877-882.
44. Taniguchi N, Honke K, Fukuda M. 2002. Handbook of glycosyltransferases and related genes. Tokyo: Springer.
45. Togayachi A, Akashima T, Ookubo R, Kudo T, Nishihara S, Iwasaki H, Natsume A, Mio H, Inokuchi J, Irimura T, et al. 2001. Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide beta 1, 3-N-acetyl- glucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J Biol Chem. 276:22032-22040.
46. Valadon P, Garnett JD, Testa JE, Bauerle M, Oh P, Schnitzer JE. 2006. Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci USA. 103:407-412.
47. Varki A. 1993. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology. 3:97-130.
48. Varki A. 2007. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 446:1023-1029.
49. Watanabe K, Hakomori SI, Childs RA, Feizi T. 1979. Characterization of a blood group I-active ganglioside. Structural requirements for I and i specificities. J Biol Chem. 254:3221-3228.
50. Watarai S, Kushi Y, Shigeto R, Misawa N, Eishi Y, Handa S, Yasuda T. 1995. Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides. J Biochem. 117:1062-1069.
51. Yago K, Zenita K, Ohwaki I, Harada R, Nozawa S, Tsukazaki K, Iwamori M, Endo N, Yasuda N, Okuma M, et al. 1993. Immunoglobulin variable region sequences of two human monoclonal antibodies directed to an onco-developmental carbohydrate antigen, lactotetraosylceramide (LcOse4Cer). Mol Immunol. 30:1481-1489.
52. Yamamoto H, Iida-Tanaka N, Kasama T, Ishizuka I, Kushi Y, Handa S. 1999. Isolation and characterization of a novel Forssman active acidic glycosphin-golipid with branched isoglobo-, ganglio-, and neolacto-series hybrid sugar chains. J Biochem. 125:923-930.
53. Yogeeswaran G. 1983. Cell surface glycolipids and glycoproteins in malignant transformation. Adv Cancer Res. 38:289-350.
54. Yu RK, Ledeen RW. 1972. Gangliosides of human, bovine, and rabbit plasma. J Lipid Res. 13:680-686.
55. Zenita K, Hirashima K, Shigeta K, Hiraiwa N, Takada A, Hashimoto K, Fujimoto E, Yago K, Kannagi R. 1990. Northern hybridization analysis of VH gene expression in murine monoclonal antibodies directed to cancer-associated ganglioside antigens having various sialic acid linkages. J Immunol. 144:4442-4451.
56. Zhuo Z-H, Zhang Y, Hu Y-F, Wahl LM, Cisar JO, Notkins AL. 2008. The broad antibacterial activity of the natural antibody repertoire is due to poly-reactive antibodies. Cell Host Microbe. 1:51-61.